Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology

por Naidoo, Jarushka, Murphy, Catherine, Atkins, Michael B, Brahmer, Julie R, Champiat, Stephane, Feltquate, David, Krug, Lee M, Moslehi, Javid, Pietanza, M Catherine, Riemer, Joanne, Robert, Caroline, Sharon, Elad, Suarez-Almazor, Maria E, Suresh, Karthik, Turner, Michelle, Weber, Jeffrey, Cappelli, Laura C
Publicado 2023

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer

por Pietanza, M. Catherine, Waqar, Saiama N., Krug, Lee M., Dowlati, Afshin, Hann, Christine L., Chiappori, Alberto, Owonikoko, Taofeek K., Woo, Kaitlin M., Cardnell, Robert J., Fujimoto, Junya, Long, Lihong, Diao, Lixia, Wang, Jing, Bensman, Yevgeniva, Hurtado, Brenda, de Groot, Patricia, Sulman, Erik P., Wistuba, Ignacio I., Chen, Alice, Fleisher, Martin, Heymach, John V., Kris, Mark G., Rudin, Charles M., Byers, Lauren Averett
Publicado 2018